课题基金 / 基金详情

项目摘要

项目成果

Lijun Rong的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction. Because of the safety concerns, these viruses are designated as the bio-safety level 4 agents. Progress in elucidation of the mechanisms of Ebola entry and pathogenesis has been hampered partly due to the safety concern. However, various surrogate systems based on the viral pseudotyping technique have been established to investigate the entry mechanism of Ebola viruses. In this application, we demonstrate that Ebola glycoprotein (GP) can be efficiently incorporated onto HIV viral particles, and the pseudotyped virions are highly infectious, as reported by others. More importantly, we show that we can use this system as a powerful entry assay to elucidate the entry mechanism of Ebola viruses. Our preliminary results clearly illustrate how we can use this pseudotyped system to dissect the roles of both subunits (GP1 and GP2) of Ebola GP in receptor recognition and viral entry. This application will focus on the following specific aims: (1) Characterization of the roles of the charged residues of the GP2 hairpin in Ebola entry. (2) Analysis of the receptor binding region of GP1 in Ebola entry. (3) Identification and characterization of the potential Ebola receptor(s). These studies will provide important information regarding how Ebola GP interacts with the cellular receptor(s) and how Ebola GP mediates efficient membrane fusion and viral entry. Furthermore, elucidation of the roles of GP1 and GP2 in Ebola entry will help us design effective Ebola entry inhibitors which may provide therapeutic treatments against Ebola infection and disease. Therefore, the research work proposed in this application is not only important for elucidating the basic entry mechanism of Ebola viruses, but also important for developing potentially powerful treatments to combat this deadly pathogen.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/jm1008715
发表时间: 2011-02-10
期刊: Journal of medicinal chemistry
影响因子: 7.3
作者: [Yermolina MV, Wang J, Caffrey M, Rong LL, Wardrop DJ]
通讯作者: Wardrop DJ
DOI: 10.1186/1743-422x-6-75
发表时间: 2009-06-08
期刊: Virology journal
影响因子: 4.8
作者: [Manicassamy B, Rong L]
通讯作者: Rong L
Identification of critical residues of influenza neuraminidase in viral particle release.
鉴定病毒颗粒释放中流感神经氨酸酶的临界残基。
DOI: 10.1186/1743-422x-8-14
发表时间: 2011-01-13
期刊: Virology journal
影响因子: 4.8
作者: [Tisoncik JR, Guo Y, Cordero KS, Yu J, Wang J, Cao Y, Rong L]
通讯作者: Rong L
Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses
Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses
Furopyrimidines as novel inhibitors of henipaviruses
  • 批准号:
    10327725
  • 项目类别:
  • 资助金额:
    $29.97万
  • 财政年份:
    2021
  • 负责人:
    Lijun Rong
  • 依托单位:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
  • 批准号:
    10256145
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    Lijun Rong
  • 依托单位:
海外基金